Genmab A/S (GNMSF)
265.27
0.00 (0.00%)
USD |
OTCM |
May 15, 16:00
Genmab Profit Margin (Quarterly) : 5.92% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Ascendis Pharma A/S | -- |
| Zealand Pharma A/S | -1.16K% |
| Bavarian Nordic A/S | 1.60% |
| Bioporto A/S | -114.3% |
| Evaxion AS | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 14.72% |
| Return on Assets | 9.06% |
| Return on Invested Capital | 10.50% |
| Gross Profit Margin (Quarterly) | 92.75% |
| Operating Margin (Quarterly) | 25.11% |
| Return on Net Operating Assets | 13.05% |